The agreement with EPA, FDA, and USAID is intended to strengthen national and global efforts. The U.S. Department of Agriculture (USDA) announced the renewal of its Federal Interagency…
Read MoreFood and Drug Administration
FDA Panel Votes Against First Proposed MDMA-Based Drug
Available data did not show a benefit to the PTSD patients for which it was intended. This week, a Food and Drug Administration (FDA) advisory panel voted against…
Read MoreFDA Recalls Cucumbers from 14 States for Salmonella
The agency directs consumers to destroy bulk whole cucumbers from Fresh Start Produce. The Food and Drug Administration (FDA) recalled whole cucumbers shipped by Fresh Start Produce Sales,…
Read MoreFDA Schedules Panel Meeting on Alzheimer’s Drug
The June meeting was scheduled after expedited approval was denied. The Food and Drug Administration (FDA) announced this week that it has scheduled a meeting of the Peripheral…
Read MoreFDA Approves Treatment for Uncomplicated UTIs
The medication, Pivya, is now an option for women with uncomplicated urinary tract infections. The Food and Drug Administration (FDA) approved Pivya tablets for treating uncomplicated urinary tract…
Read MoreHHS Postpones Menthol Cigarette Ban
Public health advocates question the delay and civil rights groups are concerned with minority health. The Department of Health and Human Services (HHS) recently moved back the implementation…
Read MoreFederal Court Places Injunction Over Sleep Therapy Device Safety Concern
Consent decree mandates remediation plan following worldwide recall, FDA oversight ensures patient safety and compliance The District Court for the Western District of Pennsylvania issued a permanent injunction…
Read MoreBiotech CEO Sentenced for Obstructing Investigation of Fake COVID-19 Tests
Keith Berman defrauded medical device investors and lied to the FDA. The CEO of a fraudulent California biotechnology company was sentenced to seven years of prison on Friday…
Read MoreFDA Approves Duchenne Muscular Dystrophy Treatment for Children
Duvyzat receives approval under fast-track designation. The U.S. Food and Drug Administration (FDA) has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne Muscular Dystrophy…
Read MoreFDA Warns Against Over-the-Counter Pain Relief Products for Cosmetic Procedures
Six companies receive warning letters as the FDA addresses unsafe topical analgesics and urges consumer vigilance. The U.S. Food and Drug Administration (FDA) has cautioned against using specific…
Read More